Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05598190

A577-nm Pro -Yellow Laser In Treatment of Striae Rubra

Conditions: Striae Rubra

Sex: Female
Healthy volunteers: 1
Phase: NA
Enrollment: 18
Sponsor: Al-Azhar University

Location: Egypt

Summary

Stretch marks or striae are common skin condition occurring in both genders, but they are more prevalent among women. These are linear dermal scars that are accompanied by epidermal atrophy. They usually occur frequently in numerous physiological and pathological conditions, such as adolescent growth, pregnancy, obesity, Cushing disease, Marfan syndrome, and long-term systemic or topical steroid use. Decreased expression of collagen and fibronectin genes has also been associated with striae.The pro-yellow laser systems can be used in a wide range of indications such as facial erythema, facial telangiectasia, port wine stain nevus, rosacea, poikilo derma civatte, and Becker's nevusSome of these indications are clinical lesions in the vascular pattern; some are related to the factors that trigger vascularity, such as vascular endothelial growth factor (VEGF) in etiopathogenesis

Eligibility Criteria

Inclusion Criteria:.Patients diagnosed with striae rubera. .Age groups: at any age. .Sex : ( females).Co-operative patientExclusion Criteria:Pregnancy .Patient using drugs exacerbating stria as topical or systemic steroid, and patients using other forms of treatment for stria as topical tretinoin, emollients, glycolic acid peel and laser, because that might affect the result of our study.Stria Alba.Skin infection (viral, bacterial or parasitic).Immunosuppressed patients or with history of malignancy or radiation therapy and chronic debilitating diseases and Cushing syndrome.Hypersensitivity to light and intak of photosensitizing drugs.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05598190). StuddyBuddy aggregates publicly available trial information.